Cellectis S.A. Files 6-K Report
Ticker: CLLS · Form: 6-K · Filed: Jun 28, 2024 · CIK: 1627281
Sentiment: neutral
Topics: filing, press-release
TL;DR
Cellectis filed a 6-K, likely with a press release attached. Check the release for news.
AI Summary
Cellectis S.A. filed a Form 6-K on June 28, 2024, to report a press release dated June 28, 2024. The filing does not contain specific financial figures or operational details beyond the announcement of the press release itself.
Why It Matters
This filing indicates that Cellectis S.A. has made a public announcement, which may contain important updates for investors regarding the company's operations or strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine report of a press release and does not contain new financial information or significant operational changes that would inherently increase risk.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- June 28, 2024 (date) — Filing date and press release date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report a press release issued by Cellectis S.A. on June 28, 2024.
What is the filing date of this report?
This report was filed on June 28, 2024.
Does Cellectis S.A. file annual reports under Form 20-F or Form 40-F?
Cellectis S.A. indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address of Cellectis S.A.?
The principal executive office address is 8, rue de la Croix Jarry, 75013 Paris, France.
What exhibit is included with this 6-K filing?
Exhibit 99.1, a Press Release dated June 28, 2024, is included with this filing.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.4 · Accepted 2024-06-28 16:35:04
Filing Documents
- f6k_062824.htm (6-K) — 4KB
- exh_991.htm (EX-99.1) — 3KB
- 0001171843-24-003705.txt ( ) — 9KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: June 28, 2024 /s/ Andr Choulika Andr Choulika Chief Executive Officer